- Home
- MRNA vs FWONK Comparison
MRNA vs FWONK Comparison
Compare MRNA & FWONK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | FWONK |
|---|---|---|
| Founded | 2010 | 1950 |
| Country | United States | United States |
| Employees | N/A | 1674 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 21.7B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | FWONK |
|---|---|---|
| Price | $45.90 | $85.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $34.27 | ★ $110.88 |
| AVG Volume (30 Days) | ★ 5.0M | 1.6M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | $24.56 |
| Revenue Next Year | $15.43 | $5.52 |
| P/E Ratio | ★ N/A | $107.00 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $80.15 |
| 52 Week High | $59.55 | $109.36 |
Technical Indicators
Market Signals| Indicator | MRNA | FWONK |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 43.35 |
| Support Level | $23.52 | $81.84 |
| Resistance Level | $55.36 | $90.85 |
| Average True Range (ATR) | 2.71 | 2.19 |
| MACD | -0.94 | -0.52 |
| Stochastic Oscillator | 12.35 | 16.89 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About FWONK Liberty Media Corporation Series C Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. It operates in two reportable segment Formula 1 and MotoGP. It generates majority of its revenue from the Formula 1 segment. The company derives its maximum revenue from United Kingdom.